Skip to main content
UniHealth

Doctor search

Glenn M Chertow, MD

Nephrology · Stanford

NPI 1407823875

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
17
3 carriers
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: 052560 · 052819 · 552582 · 552665 · 552682 · Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chertow’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence G84601 · Current

Licensed to practise in California · since 1998 · expires 2028-05-31 · Harvard Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$104,772

Medicare paid this office $104,772 for 264 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Home dialysis services per month (20 years or older)15$22,293$245
Dialysis services, 1 physician visit per month (20 years or older)18$11,017$184
Dialysis services, 2-3 physician visits per month (20 years or older)14$11,002$262
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes70$10,231$70
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes47$7,285$104
See all 13 services
Every Original Medicare service billed
Home dialysis services per month (20 years or older)15$22,293$245
Dialysis services, 1 physician visit per month (20 years or older)18$11,017$184
Dialysis services, 2-3 physician visits per month (20 years or older)14$11,002$262
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes70$10,231$70
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes47$7,285$104
Long return visit (40+ min)27$6,415$153
Hemodialysis procedure with physician evaluation46$6,382$63
Dialysis procedure including 1 evaluation25$5,862$76
Return visit (30+ min)31$3,839$120
Initial hospital care with moderate level of medical decision making at least 75 minutes24$3,575$149
Long return visit (40+ min)19$3,138$112
New patient visit (60+ min)15$3,029$202
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes16$1,866$117

Who their Medicare patients are

264 Original Medicare patients in 2024. Average age 71 · Under 65 22% · 85 and older 11% · Women 42% · Also on Medicaid 36% · Health risk score 5.30. Above the middle of the specialty; the typical nephrology clinician is at 4.01.

Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 60% · Heart failure 57% · Coronary heart disease 52% · Atrial fibrillation 43% · Cancer 26% · COPD 24% · Depression 24% · Stroke 22% · Dementia 20%.

The office billed $466,891, Medicare allowed $136,084 and paid $104,772; for 904 services of 25 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024264904715.30$466,891$104,772
2023235832724.74$419,603$91,044
2022282891724.65$431,545$95,862
20212881,043704.48$472,435$106,080
20202741,050675.43$555,290$118,632
2019226719695.13$386,328$83,811
2018243895684.69$370,511$78,851
2017229750674.85$311,537$72,738
2016240957685.02$322,199$74,919
2015229840665.19$322,884$75,471
2014282854644.99$360,145$85,226
20132791,079655.19$455,873$113,163

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 14 services

Original Medicare services billed in 2023
Home dialysis services per month (20 years or older)12$19,830$251
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes77$11,163$72
Dialysis procedure including 1 evaluation30$8,630$81
Dialysis services, 1 physician visit per month (20 years or older)12$7,500$187
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes41$7,131$110
Hemodialysis procedure with physician evaluation40$5,709$66
Long return visit (40+ min)25$5,286$143
Long return visit (40+ min)24$5,026$129
Initial hospital care with moderate level of medical decision making at least 75 minutes20$3,199$160
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes19$2,272$120
Return visit (30+ min)22$2,256$87
Return visit (30+ min)13$1,507$108
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes13$903$45
Telehealth originating site facility fee11$247$22

2022: 14 services

Original Medicare services billed in 2022
Home dialysis services per month (20 years or older)14$22,479$253
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes88$11,001$65
Dialysis services, 1 physician visit per month (20 years or older)13$8,319$189
Hemodialysis procedure with physician evaluation56$7,924$67
Long return visit (40+ min)43$6,933$122
Long return visit (40+ min)22$5,511$157
Dialysis procedure including 1 evaluation27$5,269$81
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes37$4,328$94
Initial hospital care with moderate level of medical decision making at least 75 minutes22$3,863$176
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes29$3,685$123
Return visit (30+ min)28$2,896$85
Return visit (30+ min)15$1,821$114
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes12$453$35
Telehealth originating site facility fee15$421$22

2021: 15 services

Original Medicare services billed in 2021
Home dialysis services per month (20 years or older)12$23,001$264
Dialysis services, 1 physician visit per month (20 years or older)28$12,358$184
Dialysis procedure including 1 evaluation26$10,306$82
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes86$9,892$66
Hemodialysis procedure with physician evaluation45$7,356$67
Long return visit (40+ min)32$5,821$127
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes40$5,728$95
Dialysis services, 2-3 physician visits per month (20 years or older)14$5,331$267
Long return visit (40+ min)23$4,391$163
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes27$3,383$125
Initial hospital care with moderate level of medical decision making at least 75 minutes15$2,776$185
Return visit (30+ min)27$2,731$91
Return visit (30+ min)12$1,415$94
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes13$495$35
Telehealth originating site facility fee13$346$20

2020: 17 services

Original Medicare services billed in 2020
Home dialysis services per month (20 years or older)17$23,383$207
Dialysis services, 1 physician visit per month (20 years or older)27$15,380$162
Dialysis services, 2-3 physician visits per month (20 years or older)27$12,497$223
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes80$12,038$67
Dialysis procedure including 1 evaluation31$11,268$82
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes47$7,588$97
Dialysis services, 4 or more physician visits per month (20 years or older)21$7,486$267
Hemodialysis procedure with physician evaluation47$6,840$68
Initial hospital care with moderate level of medical decision making at least 75 minutes18$3,390$188
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes21$2,712$129
Long return visit (40+ min)14$2,566$122
Return visit (30+ min)25$1,988$64
Return visit (30+ min)20$1,956$85
Telephone medical discussion with physician, 21-30 minutes11$1,705$107
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes15$1,408$94
Telehealth originating site facility fee23$749$21
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes12$436$36

2019: 13 services

Original Medicare services billed in 2019
Dialysis services, 1 physician visit per month (20 years or older)29$17,964$165
Home dialysis services per month (20 years or older)15$17,618$196
Dialysis services, 2-3 physician visits per month (20 years or older)20$8,611$205
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes51$5,310$66
Hemodialysis procedure with physician evaluation37$4,544$66
Long return visit (40+ min)25$4,096$93
Dialysis procedure including 1 evaluation12$3,729$79
Long return visit (40+ min)13$3,282$126
Return visit (30+ min)33$3,014$63
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes16$2,547$94
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes15$1,856$124
Return visit (30+ min)11$1,441$85
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes11$999$91

2018: 13 services

Original Medicare services billed in 2018
Home dialysis services per month (20 years or older)14$16,505$188
Dialysis services, 1 physician visit per month (20 years or older)13$12,734$168
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes69$8,319$64
Hemodialysis procedure with physician evaluation57$7,344$64
Dialysis procedure including 1 evaluation25$4,941$76
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes29$3,932$94
Long return visit (40+ min)20$3,438$98
Long return visit (40+ min)14$3,290$118
Return visit (30+ min)27$2,484$65
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes19$2,322$122
Return visit (30+ min)15$2,112$88
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes11$988$90
Short return visit (20+ min)15$599$40

2017: 15 services

Original Medicare services billed in 2017
Home dialysis services per month (20 years or older)14$14,949$205
Dialysis services, 1 physician visit per month (20 years or older)24$12,657$164
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes58$6,543$65
Hemodialysis procedure with physician evaluation49$5,715$64
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes29$4,394$93
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes28$3,539$122
Dialysis procedure including 1 evaluation17$3,430$78
Return visit (30+ min)34$2,996$64
Long return visit (40+ min)22$2,981$99
Dialysis services, 2-3 physician visits per month (20 years or older)13$2,865$205
Long return visit (40+ min)11$2,569$128
Initial hospital care with moderate level of medical decision making at least 75 minutes12$2,175$181
Return visit (30+ min)16$1,782$99
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes11$987$90
Short return visit (20+ min)14$639$40

2016: 13 services

Original Medicare services billed in 2016
Home dialysis services per month (20 years or older)15$13,704$208
Dialysis services, 1 physician visit per month (20 years or older)25$9,744$165
Hemodialysis procedure with physician evaluation50$6,854$64
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes56$6,109$64
Dialysis procedure including 1 evaluation22$4,613$78
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes28$3,518$93
Return visit (30+ min)34$2,918$66
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes22$2,794$121
Long return visit (40+ min)16$2,576$95
Return visit (30+ min)16$2,451$88
New patient visit (60+ min)12$2,162$180
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes14$1,216$87
Short return visit (20+ min)15$592$39

2015: 11 services

Original Medicare services billed in 2015
Home dialysis services per month (20 years or older)11$9,431$214
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes70$8,752$64
Dialysis procedure including 1 evaluation25$7,408$78
Hemodialysis procedure with physician evaluation55$7,158$64
Dialysis services, 1 physician visit per month (20 years or older)23$6,698$163
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes39$6,610$93
Long return visit (40+ min)20$3,635$91
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes28$3,415$122
Return visit (30+ min)27$2,874$67
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes16$1,615$90
Short return visit (20+ min)11$501$42

2014: 14 services

Original Medicare services billed in 2014
Dialysis services, 2-3 physician visits per month (20 years or older)28$13,911$217
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes89$10,226$63
Dialysis services, 1 physician visit per month (20 years or older)42$9,921$168
Hemodialysis procedure with physician evaluation65$9,228$64
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes56$6,932$92
Dialysis procedure including 1 evaluation20$4,752$78
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes36$4,705$121
Long return visit (40+ min)17$4,394$93
Dialysis services, 4 or more physician visits per month (20 years or older)12$4,374$257
Initial hospital care with moderate level of medical decision making at least 75 minutes22$3,913$178
Return visit (30+ min)36$3,816$62
New patient visit (45+ min)19$1,966$103
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes18$1,696$89
Short return visit (20+ min)14$637$42

2013: 15 services

Original Medicare services billed in 2013
Dialysis services, 2-3 physician visits per month (20 years or older)41$28,438$215
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes90$10,447$63
Dialysis services, 1 physician visit per month (20 years or older)31$9,243$168
Hemodialysis procedure with physician evaluation54$7,361$62
Initial hospital care with moderate level of medical decision making at least 75 minutes34$6,434$174
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes44$6,278$90
Dialysis services, 4 or more physician visits per month (20 years or older)12$4,846$255
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes35$4,676$117
Long return visit (40+ min)29$4,458$87
Dialysis procedure including 1 evaluation16$3,890$76
Return visit (30+ min)46$3,794$58
New patient visit (60+ min)12$1,637$136
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes17$1,398$78
Short return visit (20+ min)12$660$44
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes12$438$34

Medicaid work

$4,778 in 2024

Medicaid paid $4,778 for 123 billed services this clinician did in 2024, up to 20 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES93$3,107
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional30$1,672
Medicaid work by year
2024123220$4,778
2023164322$8,436
2022162223$4,986
2021196433$10,007
2020232531$21,433
2019143422$17,488
201870215$2,450
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month14$3,697
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES87$2,530
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional63$2,208

2022

Largest Medicaid services in 2022
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES131$3,772
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional31$1,214

2021

Largest Medicaid services in 2021
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month33$4,869
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES90$2,567
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional50$1,916
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES23$655

2020

Largest Medicaid services in 2020
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month31$7,445
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month26$5,452
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES111$3,624
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month24$3,356
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional40$1,555

2019

Largest Medicaid services in 2019
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month56$10,935
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month17$2,804
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES49$2,306
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional21$1,444

2018

Largest Medicaid services in 2018
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional36$1,844
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES34$606

Drugs they prescribed that Part D paid

$495,955

Pharmacies billed $495,955 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 1,367) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.

948 generic and 419 brand-name prescriptions · $495,955 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Farxiga209$201,721$965
Mounjaro43$44,968$1,046
Jardiance30$35,447$1,182
Ozempic27$25,295$937
Trulicity21$24,625$1,173
See all 30 drugs
Every Part D drug this clinician prescribed
Farxiga209$201,721$965
Mounjaro43$44,968$1,046
Jardiance30$35,447$1,182
Ozempic27$25,295$937
Trulicity21$24,625$1,173
Sevelamer Carbonate37$18,957$512
Dapagliflozin23$15,802$687
Calcium Acetate50$6,468$129
Losartan71$883$12
Chlorthalidone76$747$10
Carvedilol56$728$13
Valsartan27$651$24
Mycophenolate Mofetil14$635$45
Amlodipine Besylate86$424$5
Spironolactone19$421$22
Nifedipine Er15$395$26
Hydralazine12$365$30
Furosemide33$290$9
Telmisartan13$282$22
Ramipril24$268$11
Lactulose16$250$16
Allopurinol22$227$10
Tamsulosin17$194$11
Doxazosin Mesylate12$182$15
Calcitriol17$171$10
Levothyroxine14$164$12
Lisinopril15$156$10
Atorvastatin36$150$4
Prednisone16$119$7
Metoprolol12$89$7

Year by year

Part D prescribing by year
20241,3671760% (0)31%$495,955
20231,262165None38%$544,221
20221,0511450% (0)None$384,722
20211,1301422% (25)None$273,383
20201,0051143% (32)18%$170,412
20191,2901082% (30)27%$234,750
20181,3141003% (34)None$307,535
20171,340963% (38)25%$324,227
20161,2271003% (41)None$293,035
2015939833% (28)32%$278,538
2014944723% (24)None$206,426
2013964795% (51)32%$164,470

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 23 drugs

Part D drugs prescribed in 2023
Farxiga290$272,086$938
Trulicity50$54,987$1,100
Eliquis25$29,369$1,175
Jardiance34$27,001$794
Lokelma14$15,987$1,142
Sevelamer Carbonate21$9,158$436
Calcium Acetate47$7,076$151
Eplerenone16$1,442$90
Torsemide14$1,380$99
Losartan61$1,355$22
Carvedilol86$1,320$15
Chlorthalidone61$1,132$19
Amlodipine Besylate63$915$15
Furosemide45$864$19
Lactulose14$685$49
Tamsulosin25$614$25
Ramipril26$489$19
Atorvastatin32$433$14
Valsartan13$381$29
Allopurinol30$380$13
Lisinopril20$329$16
Gabapentin18$144$8
Spironolactone20$84$4

2022: 23 drugs

Part D drugs prescribed in 2022
Farxiga208$184,315$886
Prezcobix13$31,433$2,418
Tivicay13$28,243$2,173
Sevelamer Carbonate18$14,328$796
Jardiance20$12,968$648
Lokelma12$9,733$811
Eliquis15$9,333$622
Calcium Acetate43$6,448$150
Retacrit17$3,077$181
Torsemide17$1,018$60
Losartan57$839$15
Chlorthalidone40$766$19
Carvedilol61$611$10
Atorvastatin35$541$15
Lisinopril28$482$17
Amlodipine Besylate56$421$8
Ramipril24$351$15
Allopurinol17$319$19
Tamsulosin15$292$19
Furosemide24$280$12
Spironolactone21$139$7
Gabapentin23$135$6
Metoprolol13$38$3

2021: 26 drugs

Part D drugs prescribed in 2021
Farxiga119$90,376$759
Eliquis47$25,209$536
Cinacalcet14$12,029$859
Sevelamer Carbonate33$11,819$358
Calcium Acetate37$3,925$106
Fentanyl15$1,487$99
Losartan75$1,226$16
Cyclosporine Modified13$1,119$86
Torsemide13$1,118$86
Chlorthalidone48$911$19
Carvedilol73$806$11
Calcitriol20$667$33
Valsartan11$561$51
Amlodipine Besylate44$465$11
Famotidine21$337$16
Lisinopril41$331$8
Allopurinol19$319$17
Ramipril18$292$16
Tamsulosin16$265$17
Atorvastatin21$253$12
Metoprolol13$197$15
Furosemide23$132$6
Gabapentin20$126$6
Metformin Hcl Er17$112$7
Metoprolol24$79$3
Glipizide14$57$4

2020: 25 drugs

Part D drugs prescribed in 2020
Renvela21$46,421$2,211
Cinacalcet31$25,832$833
Eliquis31$15,357$495
Sevelamer Carbonate42$11,732$279
Prosol25$7,906$316
Calcium Acetate39$4,439$114
Torsemide19$2,085$110
Oxycodone12$1,977$165
Cyclosporine Modified11$1,538$140
Chlorthalidone46$1,246$27
Losartan65$1,210$19
Lactulose16$831$52
Carvedilol72$652$9
Allopurinol32$433$14
Famotidine19$383$20
Atorvastatin27$340$13
Metoprolol14$311$22
Amlodipine Besylate42$302$7
Levothyroxine13$297$23
Tamsulosin16$214$13
Ramipril11$198$18
Lisinopril21$171$8
Furosemide24$154$6
Metoprolol28$97$3
Gabapentin23$78$3

2019: 29 drugs

Part D drugs prescribed in 2019
Renvela25$36,149$1,446
Cinacalcet14$28,115$2,008
Sevelamer Carbonate40$22,764$569
Prosol82$18,576$227
Auryxia23$17,389$756
Eliquis17$7,695$453
Intralipid53$6,840$129
Calcium Acetate39$3,580$92
Clinisol21$3,186$152
Chlorthalidone90$2,210$25
Dextrose in Water53$1,017$19
Lactulose19$1,010$53
Losartan69$966$14
Carvedilol65$751$12
Allopurinol52$688$13
Torsemide20$597$30
Metoprolol16$586$37
Ramipril20$502$25
Atorvastatin37$469$13
Amlodipine Besylate60$464$8
Calcitriol16$384$24
Levothyroxine21$370$18
Furosemide41$365$9
Famotidine20$174$9
Hydrocodone-Acetaminophen16$173$11
Lisinopril13$165$13
Omeprazole19$106$6
Gabapentin16$104$6
Metoprolol24$76$3

2018: 32 drugs

Part D drugs prescribed in 2018
Renvela57$80,827$1,418
Sensipar36$57,203$1,589
Sevelamer Carbonate35$35,266$1,008
Auryxia16$17,977$1,124
Prosol41$8,643$211
Intralipid41$5,281$129
Calcium Acetate44$4,483$102
Clinisol15$2,283$152
Chlorthalidone70$1,818$26
Metolazone14$913$65
Losartan85$893$11
Omega-3 Acid Ethyl Esters12$741$62
Carvedilol73$735$10
Fentanyl11$623$57
Torsemide31$618$20
Allopurinol55$586$11
Amlodipine Besylate69$414$6
Atorvastatin20$345$17
Labetalol16$327$20
Furosemide52$320$6
Tamsulosin11$251$23
Levothyroxine13$203$16
Famotidine33$193$6
Lisinopril29$180$6
Dextrose in Water41$176$4
Ramipril14$165$12
Hydrocodone-Acetaminophen16$162$10
Ondansetron13$95$7
Omeprazole13$95$7
Gabapentin14$85$6
Sulfamethoxazole-Trimethoprim18$48$3
Montelukast12$42$4

2017: 34 drugs

Part D drugs prescribed in 2017
Sensipar117$119,576$1,022
Renvela70$94,893$1,356
Xifaxan12$24,023$2,002
Clinisol92$14,114$153
Uloric14$5,062$362
Calcium Acetate44$4,258$97
Torsemide49$1,109$23
Hydroxychloroquine Sulfate11$994$90
Isradipine12$993$83
Fentanyl13$855$66
Labetalol22$840$38
Carvedilol93$796$9
Chlorthalidone34$790$23
Metolazone22$770$35
Allopurinol43$763$18
Omega-3 Acid Ethyl Esters12$727$61
Losartan54$531$10
Amlodipine Besylate100$475$5
Furosemide66$458$7
Bupropion11$385$35
Tamsulosin17$314$18
Atorvastatin24$311$13
Levothyroxine20$298$15
Calcitriol11$251$23
Valsartan11$220$20
Hydrocodone-Acetaminophen20$212$11
Metoprolol11$175$16
Lisinopril31$161$5
Famotidine25$116$5
Pantoprazole12$100$8
Doxazosin Mesylate11$96$9
Gabapentin13$77$6
Montelukast13$76$6
Trazodone13$33$3

2016: 33 drugs

Part D drugs prescribed in 2016
Renvela89$122,615$1,378
Sensipar80$91,054$1,138
Clinisol60$9,044$151
Uloric16$6,029$377
Calcium Acetate34$3,386$100
Plavix12$2,550$213
Clonidine18$2,350$131
Labetalol24$1,347$56
Omega-3 Acid Ethyl Esters12$852$71
Fentanyl13$764$59
Chlorthalidone25$662$26
Torsemide53$659$12
Isradipine11$608$55
Nifedipine Er11$510$46
Amlodipine Besylate81$474$6
Allopurinol31$412$13
Carvedilol66$365$6
Furosemide56$356$6
Levothyroxine28$343$12
Ramipril20$326$16
Tamsulosin17$319$19
Metoprolol20$295$15
Losartan41$280$7
Hydrocodone-Acetaminophen19$273$14
Calcitriol11$263$24
Bupropion12$262$22
Atorvastatin24$196$8
Clonidine13$173$13
Pantoprazole17$153$9
Montelukast12$149$12
Lisinopril37$147$4
Doxazosin Mesylate11$111$10
Trazodone18$41$2

2015: 24 drugs

Part D drugs prescribed in 2015
Renvela97$125,683$1,296
Sensipar101$118,820$1,176
Clinisol49$9,167$187
Calcium Acetate23$3,355$146
Plavix14$2,975$213
Omega-3 Acid Ethyl Esters11$1,124$102
Fentanyl11$837$76
Metoprolol14$580$41
Chlorthalidone18$464$26
Torsemide31$423$14
Amlodipine Besylate90$329$4
Acyclovir12$268$22
Furosemide45$245$5
Atorvastatin32$244$8
Montelukast14$232$17
Armour Thyroid12$182$15
Lisinopril31$180$6
Levothyroxine15$170$11
Carvedilol34$143$4
Clonidine12$122$10
Allopurinol11$109$10
Omeprazole11$94$9
Escitalopram15$69$5
Losartan19$67$4

2014: 23 drugs

Part D drugs prescribed in 2014
Sensipar88$77,194$877
Renvela66$74,657$1,131
Clinisol34$5,556$163
Calcium Acetate27$5,143$190
Paricalcitol11$3,755$341
Plavix12$2,550$213
Lovaza13$2,264$174
Prosol12$1,805$150
Intralipid16$1,306$82
Metoprolol38$1,058$28
Torsemide27$787$29
Ramipril31$589$19
Chlorthalidone24$441$18
Atorvastatin30$386$13
Amlodipine Besylate57$286$5
Pravastatin13$286$22
Lisinopril32$265$8
Carvedilol40$209$5
Furosemide30$148$5
Omeprazole19$127$7
Gabapentin11$94$9
Clonidine14$67$5
Fluoxetine13$65$5

2013: 30 drugs

Part D drugs prescribed in 2013
Renvela84$69,872$832
Sensipar48$41,092$856
Calcium Acetate35$6,134$175
Intralipid51$5,339$105
Clinisol25$3,416$137
Lipitor14$2,702$193
Lovaza11$1,648$150
Labetalol18$942$52
Metoprolol20$674$34
Ramipril41$556$14
Amlodipine Besylate44$251$6
Gabapentin27$241$9
Carvedilol31$230$7
Atorvastatin15$228$15
Furosemide38$226$6
Omeprazole14$192$14
Methadone13$180$14
Simvastatin12$169$14
Lisinopril22$167$8
Hydrocodone-Acetaminophen19$163$9
Chlorthalidone11$153$14
Clonidine23$153$7
Calcitriol14$128$9
Levothyroxine12$126$11
Pravastatin13$118$9
Prednisone17$113$7
Losartan12$76$6
Fluoxetine13$76$6
Amitriptyline13$69$5
Armour Thyroid11$59$5

Money from drug and device companies

$322,959 in 2025

Industry payments by year
20251283$312,917$322,959
20241566$273,073$276,263
20231136$343,519$344,512
20221252$442,541$442,923
20211135$385,411$385,411
2020921$67,313$67,313
2019962$165,608$182,198

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Akebia TherapeuticsVafseo$89,878
13 payments
  • Consulting for Vafseo · 2025-12-18 · $8,940
  • Meals for Auryxia · 2025-11-05 · $123
  • Consulting for Vafseo · 2025-08-06 · $11,548
  • Consulting for Vafseo · 2025-05-28 · $44,328
  • Consulting for Vafseo · 2025-01-21 · $2,500
  • Consulting for Vafseo · 2025-01-21 · $16,800
  • Travel for Vafseo · 2025-01-21 · $388
  • Travel for Vafseo · 2025-01-21 · $582
  • Travel for Vafseo · 2025-01-21 · $62
  • Travel for Vafseo · 2025-01-21 · $51
  • Travel for Vafseo · 2025-01-21 · $42
  • Travel for Vafseo · 2025-01-21 · $46
  • Consulting for Vafseo · 2025-01-08 · $4,470
Vertex PharmaceuticalsNone$82,483
17 payments
  • Meals · 2025-12-17 · $104
  • Travel · 2025-12-17 · $155
  • Travel · 2025-12-17 · $362
  • Travel · 2025-12-17 · $541
  • Meals · 2025-11-06 · $28
  • Consulting · 2025-10-22 · $28,800
  • Consulting · 2025-07-16 · $7,650
  • Meals · 2025-06-05 · $69
  • Consulting · 2025-05-21 · $9,000
  • Travel · 2025-04-09 · $262
  • Travel · 2025-04-09 · $68
  • Meals · 2025-04-09 · $21
  • Consulting · 2025-04-09 · $13,500
  • Travel · 2025-03-19 · $255
  • Meals · 2025-03-19 · $28
  • Meals · 2025-03-19 · $42
  • Consulting · 2025-03-05 · $21,600
AstraZeneca Pharmaceuticals LPFarxiga$77,441
24 payments
  • Consulting for Farxiga · 2025-12-23 · $1,050
  • Consulting for Farxiga · 2025-12-11 · $1,400
  • Consulting for Farxiga · 2025-12-10 · $700
  • Consulting for Farxiga · 2025-12-10 · $1,400
  • Consulting for Farxiga · 2025-12-05 · $700
  • Consulting for Farxiga · 2025-12-04 · $1,750
  • Consulting · 2025-10-29 · $12,600
  • Consulting · 2025-10-16 · $11,200
  • Consulting · 2025-09-11 · $9,800
  • Consulting · 2025-09-11 · $1,400
  • Consulting for Farxiga · 2025-08-15 · $1,400
  • Consulting · 2025-08-01 · $2,300
  • Consulting · 2025-07-23 · $1,400
  • Consulting for Farxiga · 2025-07-18 · $1,400
  • Consulting · 2025-07-18 · $3,500
  • Consulting · 2025-07-15 · $9,100
  • Consulting · 2025-07-09 · $2,100
  • Travel · 2025-06-06 · $9
  • Meals · 2025-06-06 · $57
  • Consulting · 2025-05-22 · $5,250
  • Consulting · 2025-05-09 · $1,725
  • Consulting for Farxiga · 2025-04-15 · $2,100
  • Consulting · 2025-03-06 · $2,300
  • Consulting · 2025-01-23 · $2,800
AstraZeneca UKFarxiga$34,026
11 payments
  • Consulting for Farxiga · 2025-12-18 · $4,000
  • Meals · 2025-11-05 · $76
  • Consulting for Farxiga · 2025-10-24 · $10,400
  • Consulting for Farxiga · 2025-09-17 · $4,800
  • Consulting for Farxiga · 2025-08-27 · $1,500
  • Consulting · 2025-07-21 · $500
  • Consulting for Farxiga · 2025-07-14 · $575
  • Consulting for Farxiga · 2025-06-03 · $575
  • Consulting for Farxiga · 2025-05-22 · $5,600
  • Consulting for Lokelma · 2025-05-22 · $1,000
  • Consulting for Lokelma · 2025-05-15 · $5,000
Travere TherapeuticsNone$16,000
2 payments
  • Consulting · 2025-09-02 · $10,000
  • Consulting · 2025-07-29 · $6,000
CSL BehringNone$10,390
8 payments
  • Consulting · 2025-07-14 · $542
  • Consulting · 2025-07-14 · $542
  • Consulting · 2025-06-27 · $2,892
  • Travel · 2025-01-22 · $386
  • Travel · 2025-01-22 · $65
  • Meals · 2025-01-21 · $21
  • Travel · 2025-01-20 · $5,877
  • Travel · 2025-01-20 · $65
See all 83 published payments
Every published payment
GlaxoSmithKlineConsulting · 2025-12-24None$5,000
AstraZeneca Pharmaceuticals LPConsulting · 2025-12-23Farxiga$1,050
AstraZeneca UKConsulting · 2025-12-18Farxiga$4,000
Akebia TherapeuticsConsulting · 2025-12-18Vafseo$8,940
Vertex PharmaceuticalsMeals · 2025-12-17None$104
Vertex PharmaceuticalsTravel · 2025-12-17None$155
Vertex PharmaceuticalsTravel · 2025-12-17None$362
Vertex PharmaceuticalsTravel · 2025-12-17None$541
AstraZeneca Pharmaceuticals LPConsulting · 2025-12-11Farxiga$1,400
AstraZeneca Pharmaceuticals LPConsulting · 2025-12-10Farxiga$700
AstraZeneca Pharmaceuticals LPConsulting · 2025-12-10Farxiga$1,400
AstraZeneca Pharmaceuticals LPConsulting · 2025-12-05Farxiga$700
AstraZeneca Pharmaceuticals LPConsulting · 2025-12-04Farxiga$1,750
GlaxoSmithKlineConsulting · 2025-12-02None$1,000
Vertex PharmaceuticalsMeals · 2025-11-06None$28
Bayer Healthcare PharmaceuticalsMeals · 2025-11-06None$120
AstraZeneca UKMeals · 2025-11-05None$76
Akebia TherapeuticsMeals · 2025-11-05Auryxia$123
ArdelyxMeals · 2025-11-05Ibsrela$32
AstraZeneca Pharmaceuticals LPConsulting · 2025-10-29None$12,600
AstraZeneca UKConsulting · 2025-10-24Farxiga$10,400
Vertex PharmaceuticalsConsulting · 2025-10-22None$28,800
AstraZeneca Pharmaceuticals LPConsulting · 2025-10-16None$11,200
AstraZeneca UKConsulting · 2025-09-17Farxiga$4,800
AstraZeneca Pharmaceuticals LPConsulting · 2025-09-11None$9,800
AstraZeneca Pharmaceuticals LPConsulting · 2025-09-11None$1,400
Travere TherapeuticsConsulting · 2025-09-02None$10,000
AstraZeneca UKConsulting · 2025-08-27Farxiga$1,500
AstraZeneca Pharmaceuticals LPConsulting · 2025-08-15Farxiga$1,400
Alnylam PharmaceuticalsConsulting · 2025-08-14None$4,900
Akebia TherapeuticsConsulting · 2025-08-06Vafseo$11,548
AstraZeneca Pharmaceuticals LPConsulting · 2025-08-01None$2,300
Travere TherapeuticsConsulting · 2025-07-29None$6,000
AstraZeneca Pharmaceuticals LPConsulting · 2025-07-23None$1,400
AstraZeneca UKConsulting · 2025-07-21None$500
AstraZeneca Pharmaceuticals LPConsulting · 2025-07-18Farxiga$1,400
AstraZeneca Pharmaceuticals LPConsulting · 2025-07-18None$3,500
Vertex PharmaceuticalsConsulting · 2025-07-16None$7,650
AstraZeneca Pharmaceuticals LPConsulting · 2025-07-15None$9,100
AstraZeneca UKConsulting · 2025-07-14Farxiga$575
CSL BehringConsulting · 2025-07-14None$542
CSL BehringConsulting · 2025-07-14None$542
GlaxoSmithKlineConsulting · 2025-07-11None$1,000
AstraZeneca Pharmaceuticals LPConsulting · 2025-07-09None$2,100
CSL BehringConsulting · 2025-06-27None$2,892
InsmedConsulting · 2025-06-24None$580
Novo NordiskMeals · 2025-06-23Ozempic$108
AstraZeneca Pharmaceuticals LPTravel · 2025-06-06None$9
AstraZeneca Pharmaceuticals LPMeals · 2025-06-06None$57
Vertex PharmaceuticalsMeals · 2025-06-05None$69
AstraZeneca UKConsulting · 2025-06-03Farxiga$575
Akebia TherapeuticsConsulting · 2025-05-28Vafseo$44,328
AstraZeneca UKConsulting · 2025-05-22Farxiga$5,600
AstraZeneca UKConsulting · 2025-05-22Lokelma$1,000
AstraZeneca Pharmaceuticals LPConsulting · 2025-05-22None$5,250
Vertex PharmaceuticalsConsulting · 2025-05-21None$9,000
AstraZeneca UKConsulting · 2025-05-15Lokelma$5,000
AstraZeneca Pharmaceuticals LPConsulting · 2025-05-09None$1,725
AstraZeneca Pharmaceuticals LPConsulting · 2025-04-15Farxiga$2,100
Vertex PharmaceuticalsTravel · 2025-04-09None$262
Vertex PharmaceuticalsTravel · 2025-04-09None$68
Vertex PharmaceuticalsMeals · 2025-04-09None$21
Vertex PharmaceuticalsConsulting · 2025-04-09None$13,500
Vertex PharmaceuticalsTravel · 2025-03-19None$255
Vertex PharmaceuticalsMeals · 2025-03-19None$28
Vertex PharmaceuticalsMeals · 2025-03-19None$42
AstraZeneca Pharmaceuticals LPConsulting · 2025-03-06None$2,300
Vertex PharmaceuticalsConsulting · 2025-03-05None$21,600
AstraZeneca Pharmaceuticals LPConsulting · 2025-01-23None$2,800
CSL BehringTravel · 2025-01-22None$386
CSL BehringTravel · 2025-01-22None$65
CSL BehringMeals · 2025-01-21None$21
Akebia TherapeuticsConsulting · 2025-01-21Vafseo$2,500
Akebia TherapeuticsConsulting · 2025-01-21Vafseo$16,800
Akebia TherapeuticsTravel · 2025-01-21Vafseo$388
Akebia TherapeuticsTravel · 2025-01-21Vafseo$582
Akebia TherapeuticsTravel · 2025-01-21Vafseo$62
Akebia TherapeuticsTravel · 2025-01-21Vafseo$51
Akebia TherapeuticsTravel · 2025-01-21Vafseo$42
Akebia TherapeuticsTravel · 2025-01-21Vafseo$46
CSL BehringTravel · 2025-01-20None$5,877
CSL BehringTravel · 2025-01-20None$65
Akebia TherapeuticsConsulting · 2025-01-08Vafseo$4,470
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $276,263

Payments by company in 2024
AstraZeneca Pharmaceuticals LPNone$110,905
23 payments
  • Consulting · 2024-12-18 · $62,300
  • Travel · 2024-12-16 · $567
  • Meals · 2024-12-16 · $29
  • Travel · 2024-12-16 · $299
  • Consulting · 2024-11-20 · $1,050
  • Consulting · 2024-11-13 · $1,750
  • Consulting · 2024-11-06 · $700
  • Meals · 2024-10-23 · $81
  • Consulting · 2024-10-01 · $3,500
  • Travel · 2024-06-11 · $359
  • Meals · 2024-06-11 · $50
  • Meals · 2024-06-11 · $35
  • Travel · 2024-06-11 · $205
  • Meals · 2024-06-11 · $35
  • Travel · 2024-06-11 · $591
  • Travel · 2024-06-11 · $90
  • Meals · 2024-06-11 · $40
  • Travel · 2024-05-23 · $14
  • Meals · 2024-05-23 · $55
  • Meals · 2024-04-04 · $107
  • Consulting · 2024-03-05 · $11,275
  • Consulting · 2024-03-03 · $15,400
  • Consulting · 2024-02-20 · $12,375
Vertex PharmaceuticalsNone$70,763
10 payments
  • Consulting · 2024-11-20 · $29,255
  • Meals · 2024-10-25 · $29
  • Consulting · 2024-07-03 · $21,600
  • Consulting · 2024-06-26 · $19,350
  • Meals · 2024-05-25 · $5
  • Meals · 2024-05-25 · $2
  • Meals · 2024-05-25 · $13
  • Meals · 2024-05-25 · $7
  • Meals · 2024-05-25 · $2
  • Consulting · 2024-04-12 · $500
Outset MedicalNone$46,500
2 payments
  • Consulting · 2024-02-24 · $23,250
  • Consulting · 2024-02-24 · $23,250
ArdelyxXphozah 30 Mg$25,200
10 payments
  • Consulting for Xphozah 30 Mg · 2024-09-05 · $875
  • Consulting for Xphozah 30 Mg · 2024-08-13 · $875
  • Consulting for Xphozah 30 Mg · 2024-07-30 · $875
  • Consulting for Xphozah 30 Mg · 2024-06-04 · $875
  • Consulting for Xphozah 30 Mg · 2024-05-08 · $875
  • Consulting for Xphozah 30 Mg · 2024-04-30 · $875
  • Consulting for Xphozah 30 Mg · 2024-03-22 · $16,100
  • Consulting for Xphozah 30 Mg · 2024-03-09 · $1,050
  • Consulting for Xphozah 30 Mg · 2024-02-21 · $1,050
  • Consulting for Xphozah 30 Mg · 2024-01-24 · $1,750
Akebia TherapeuticsVafseo$6,268
4 payments
  • Meals for Auryxia · 2024-10-23 · $125
  • Meals · 2024-05-25 · $90
  • Consulting for Vafseo · 2024-03-18 · $5,960
  • Meals · 2024-03-09 · $92
AstraZeneca UKFarxiga$6,250
5 payments
  • Consulting · 2024-03-11 · $500
  • Consulting · 2024-03-11 · $500
  • Consulting · 2024-03-11 · $3,250
  • Consulting for Farxiga · 2024-02-15 · $500
  • Consulting for Farxiga · 2024-01-09 · $1,500
ZOLL MedicalDefibrillator$3,017
3 payments
  • Consulting for Defibrillator · 2024-08-26 · $1,100
  • Consulting for Defibrillator · 2024-08-09 · $917
  • Consulting for Defibrillator · 2024-05-10 · $1,000
Alexion PharmaceuticalsNone$2,010
1 payment
  • Consulting · 2024-03-20 · $2,010
AstraZeneca ABNone$1,725
1 payment
  • Consulting · 2024-08-01 · $1,725
Baxter HealthcareRenal - Theranova$1,240
1 payment
  • Consulting for Renal - Theranova · 2024-11-14 · $1,240
InsmedNone$1,117
1 payment
  • Consulting · 2024-10-23 · $1,117
BeiGene USANone$1,000
1 payment
  • Consulting · 2024-10-22 · $1,000
Bayer Healthcare PharmaceuticalsKerendia$146
1 payment
  • Meals for Kerendia · 2024-10-24 · $146
Novartis PharmaceuticalsFabhalta$65
2 payments
  • Meals for Fabhalta · 2024-10-23 · $34
  • Meals · 2024-03-09 · $31
Aurinia Pharma U.S.Lupkynis$58
1 payment
  • Meals for Lupkynis · 2024-03-12 · $58

2023: $344,512

Payments by company in 2023
Outset MedicalNone$159,884
2 payments
  • Paid to speak or teach · 2023-12-31 · $159,377
  • Meals · 2023-09-21 · $507
Vertex PharmaceuticalsNone$64,345
7 payments
  • Consulting · 2023-12-20 · $2,250
  • Consulting · 2023-11-15 · $21,600
  • Meals · 2023-11-03 · $54
  • Consulting · 2023-10-04 · $21,600
  • Consulting · 2023-06-27 · $13,500
  • Consulting · 2023-03-16 · $542
  • Consulting · 2023-02-15 · $4,800
ArdelyxXphozah 30 Mg$47,900
5 payments
  • Consulting for Xphozah 30 Mg · 2023-12-20 · $4,900
  • Consulting for Xphozah 30 Mg · 2023-10-16 · $21,000
  • Consulting for Xphozah 30 Mg · 2023-09-05 · $14,000
  • Consulting for Xphozah 30 Mg · 2023-08-28 · $3,000
  • Consulting for Xphozah 30 Mg · 2023-01-16 · $5,000
AstraZeneca Pharmaceuticals LPNone$38,625
5 payments
  • Consulting · 2023-12-26 · $17,875
  • Consulting · 2023-05-15 · $500
  • Consulting · 2023-01-19 · $11,000
  • Consulting · 2023-01-19 · $8,250
  • Consulting · 2023-01-13 · $1,000
AstraZeneca UKNone$20,250
8 payments
  • Consulting · 2023-12-21 · $4,000
  • Consulting · 2023-10-05 · $2,750
  • Consulting · 2023-05-30 · $3,000
  • Consulting · 2023-05-30 · $3,000
  • Consulting · 2023-05-12 · $1,000
  • Consulting · 2023-05-12 · $500
  • Consulting · 2023-05-12 · $3,500
  • Consulting · 2023-02-14 · $2,500
Akebia TherapeuticsNone$11,500
2 payments
  • Consulting · 2023-09-14 · $6,000
  • Consulting · 2023-02-16 · $5,500
Novo Nordisk ASNone$1,575
1 payment
  • Consulting · 2023-11-21 · $1,575
Bayer Healthcare PharmaceuticalsKerendia$183
3 payments
  • Meals for Kerendia · 2023-11-02 · $95
  • Meals for Kerendia · 2023-04-26 · $14
  • Meals for Kerendia · 2023-04-26 · $75
AmgenTavneos$122
1 payment
  • Meals for Tavneos · 2023-04-12 · $122
Alexion PharmaceuticalsUltomiris$100
1 payment
  • Meals for Ultomiris · 2023-11-27 · $100
Travere TherapeuticsNone$28
1 payment
  • Meals · 2023-11-01 · $28

2022: $442,923

Payments by company in 2022
Outset MedicalNone$145,671
1 payment
  • Consulting · 2022-12-31 · $145,671
ArdelyxNone$120,600
11 payments
  • Consulting · 2022-11-21 · $39,680
  • Consulting · 2022-10-10 · $5,000
  • Consulting · 2022-10-04 · $25,730
  • Consulting · 2022-08-22 · $15,190
  • Consulting · 2022-08-22 · $5,000
  • Consulting · 2022-07-20 · $5,000
  • Consulting · 2022-07-20 · $5,000
  • Consulting · 2022-07-20 · $5,000
  • Consulting · 2022-07-20 · $5,000
  • Consulting · 2022-07-20 · $5,000
  • Consulting · 2022-07-20 · $5,000
AstraZeneca Pharmaceuticals LPLokelma$63,250
12 payments
  • Consulting for Lokelma · 2022-12-12 · $1,000
  • Consulting for Farxiga · 2022-11-11 · $1,000
  • Consulting for Lokelma · 2022-11-03 · $1,000
  • Consulting for Farxiga · 2022-10-28 · $1,000
  • Consulting for Lokelma · 2022-10-25 · $1,500
  • Consulting · 2022-09-22 · $18,250
  • Consulting for Lokelma · 2022-08-15 · $4,000
  • Consulting for Farxiga · 2022-07-28 · $1,000
  • Consulting · 2022-06-16 · $15,000
  • Consulting for Farxiga · 2022-06-05 · $1,250
  • Consulting · 2022-05-12 · $15,000
  • Consulting · 2022-03-10 · $3,250
Akebia TherapeuticsNone$46,750
7 payments
  • Consulting · 2022-11-18 · $2,500
  • Consulting · 2022-08-04 · $5,250
  • Consulting · 2022-06-16 · $11,250
  • Consulting · 2022-06-16 · $11,250
  • Consulting · 2022-05-11 · $1,500
  • Consulting · 2022-01-27 · $4,750
  • Consulting · 2022-01-20 · $10,250
Vertex PharmaceuticalsNone$21,433
4 payments
  • Meals · 2022-11-04 · $73
  • Consulting · 2022-10-26 · $6,000
  • Consulting · 2022-07-20 · $12,000
  • Consulting · 2022-04-20 · $3,360
Gilead SciencesNone$17,750
4 payments
  • Consulting · 2022-06-22 · $6,000
  • Consulting · 2022-06-20 · $6,750
  • Consulting · 2022-05-23 · $3,500
  • Consulting · 2022-01-19 · $1,500
GlaxoSmithKlineNone$11,067
2 payments
  • Consulting · 2022-12-13 · $11,050
  • Meals · 2022-11-02 · $17
AstraZeneca UKFarxiga$9,375
4 payments
  • Meals · 2022-11-05 · $125
  • Consulting · 2022-05-25 · $1,250
  • Consulting · 2022-02-15 · $6,000
  • Consulting for Farxiga · 2022-02-08 · $2,000
AstraZeneca ABNone$2,500
1 payment
  • Consulting · 2022-05-27 · $2,500
Travere TherapeuticsNone$2,000
1 payment
  • Consulting · 2022-07-27 · $2,000
Bayer HealthCare PharmaceuticalsKerendia$1,870
3 payments
  • Consulting for Kerendia · 2022-11-21 · $1,750
  • Meals for Kerendia · 2022-07-12 · $106
  • Meals for Kerendia · 2022-05-17 · $14
AmgenTavneos$656
2 payments
  • Consulting for Tavneos · 2022-12-07 · $610
  • Meals for Tavneos · 2022-11-04 · $46

2021: $385,411

Payments by company in 2021
Outset MedicalNone$289,961
10 payments
  • Consulting · 2021-12-27 · $15,581
  • Consulting · 2021-11-22 · $16,567
  • Consulting · 2021-10-22 · $45,193
  • Consulting · 2021-09-01 · $26,605
  • Consulting · 2021-07-22 · $23,255
  • Consulting · 2021-06-30 · $26,683
  • Consulting · 2021-05-25 · $24,793
  • Consulting · 2021-04-22 · $30,640
  • Consulting · 2021-03-24 · $27,714
  • Consulting · 2021-02-22 · $52,931
Akebia TherapeuticsAuryxia$56,610
7 payments
  • Consulting · 2021-11-19 · $2,360
  • Consulting for Auryxia · 2021-11-10 · $21,000
  • Consulting for Auryxia · 2021-09-02 · $3,500
  • Consulting for Auryxia · 2021-09-02 · $2,500
  • Consulting for Auryxia · 2021-05-19 · $9,750
  • Consulting for Auryxia · 2021-03-23 · $2,000
  • Consulting for Auryxia · 2021-02-17 · $15,500
Gilead SciencesNone$13,220
5 payments
  • Consulting · 2021-10-11 · $3,500
  • Consulting · 2021-08-11 · $2,750
  • Consulting · 2021-06-02 · $4,470
  • Consulting · 2021-04-19 · $1,500
  • Consulting · 2021-01-11 · $1,000
AstraZeneca ABFarxiga$7,000
2 payments
  • Consulting · 2021-07-15 · $5,000
  • Consulting for Farxiga · 2021-01-06 · $2,000
Otsuka Pharmaceutical Development & CommercializationNone$5,440
1 payment
  • Consulting · 2021-06-14 · $5,440
Vertex PharmaceuticalsNone$5,118
4 payments
  • Consulting · 2021-11-10 · $2,880
  • Consulting · 2021-08-18 · $960
  • Consulting · 2021-03-17 · $720
  • Consulting · 2021-01-11 · $558
CSL BehringNone$3,026
1 payment
  • Consulting · 2021-09-13 · $3,026
Travere TherapeuticsNone$2,000
2 payments
  • Consulting · 2021-07-11 · $1,000
  • Consulting · 2021-07-11 · $1,000
AstraZeneca Pharmaceuticals LPNone$1,250
1 payment
  • Consulting · 2021-01-18 · $1,250
Alnylam PharmaceuticalsNone$960
1 payment
  • Consulting · 2021-02-03 · $960
Lilly USAJardiance$825
1 payment
  • Consulting for Jardiance · 2021-09-03 · $825

2020: $67,313

Payments by company in 2020
Akebia TherapeuticsAuryxia$28,500
6 payments
  • Consulting · 2020-11-16 · $6,500
  • Consulting · 2020-09-16 · $9,500
  • Consulting for Auryxia · 2020-08-05 · $4,000
  • Consulting · 2020-07-15 · $4,750
  • Consulting for Auryxia · 2020-01-07 · $2,000
  • Consulting for Auryxia · 2020-01-07 · $1,750
Gilead SciencesNone$11,500
2 payments
  • Consulting · 2020-10-21 · $7,500
  • Consulting · 2020-03-16 · $4,000
AstraZeneca ABFarxiga$9,000
4 payments
  • Consulting for Farxiga · 2020-10-07 · $2,000
  • Consulting for Lokelma · 2020-08-04 · $1,500
  • Consulting for Farxiga · 2020-07-03 · $5,000
  • Consulting for Lokelma · 2020-03-26 · $500
Vertex PharmaceuticalsNone$6,240
3 payments
  • Consulting · 2020-12-18 · $1,440
  • Consulting · 2020-08-12 · $1,920
  • Consulting · 2020-05-20 · $2,880
AstraZeneca Pharmaceuticals LPNone$4,279
1 payment
  • Consulting · 2020-06-12 · $4,279
Bayer HealthCare PharmaceuticalsNon-Covered$3,360
2 payments
  • Consulting for Non-Covered · 2020-08-25 · $2,520
  • Consulting for Non-Covered · 2020-08-25 · $840
AstraZeneca UKNone$3,112
1 payment
  • Consulting · 2020-09-15 · $3,112
Otsuka Pharmaceutical Development & CommercializationNone$1,005
1 payment
  • Consulting · 2020-11-17 · $1,005
Vifor (International)None$317
1 payment
  • Consulting · 2020-02-28 · $317

2019: $182,198

Payments by company in 2019
Akebia TherapeuticsAuryxia$72,307
9 payments
  • Consulting · 2019-11-18 · $8,110
  • Meals for Auryxia · 2019-10-17 · $19
  • Consulting · 2019-09-10 · $10,347
  • Consulting · 2019-08-01 · $6,000
  • Consulting · 2019-05-22 · $10,080
  • Consulting · 2019-05-08 · $9,954
  • Consulting · 2019-03-20 · $9,922
  • Consulting · 2019-01-23 · $7,963
  • Consulting · 2019-01-16 · $9,913
Gilead SciencesNone$51,159
11 payments
  • Consulting · 2019-12-20 · $9,000
  • Meals · 2019-11-06 · $98
  • Consulting · 2019-10-14 · $7,500
  • Travel · 2019-10-02 · $435
  • Consulting · 2019-09-25 · $10,000
  • Consulting · 2019-04-15 · $1,750
  • Consulting · 2019-02-04 · $4,250
  • Travel · 2019-01-16 · $832
  • Meals · 2019-01-16 · $43
  • Consulting · 2019-01-03 · $6,250
  • Consulting · 2019-01-03 · $11,000
AstraZeneca ABFarxiga$20,250
2 payments
  • Consulting for Farxiga · 2019-12-13 · $19,750
  • Consulting · 2019-02-25 · $500
Bayer HealthCare PharmaceuticalsNon-Covered$20,076
14 payments
  • Travel for Non-Covered · 2019-12-20 · $7,490
  • Travel for Non-Covered · 2019-10-08 · $35
  • Travel for Non-Covered · 2019-10-08 · $3,780
  • Travel for Non-Covered · 2019-10-08 · $55
  • Travel for Non-Covered · 2019-10-08 · $144
  • Travel for Non-Covered · 2019-10-08 · $36
  • Consulting for Non-Covered · 2019-10-08 · $4,200
  • Travel for Non-Covered · 2019-09-25 · $212
  • Meals for Non-Covered · 2019-09-25 · $87
  • Meals for Non-Covered · 2019-09-25 · $23
  • Meals for Non-Covered · 2019-09-25 · $57
  • Meals for Non-Covered · 2019-09-25 · $35
  • Travel for Non-Covered · 2019-08-26 · $353
  • Consulting for Non-Covered · 2019-03-14 · $3,570
Baxter HealthcareRenal - Theranova$13,244
8 payments
  • Consulting for Renal - Theranova · 2019-03-19 · $12,600
  • Travel for Renal - Theranova · 2019-03-19 · $158
  • Travel for Renal - Theranova · 2019-03-19 · $169
  • Travel for Renal - Theranova · 2019-03-19 · $180
  • Travel for Renal - Theranova · 2019-03-19 · $52
  • Travel for Renal - Theranova · 2019-03-19 · $62
  • Meals for Renal - Theranova · 2019-03-19 · $3
  • Meals for Renal - Theranova · 2019-03-19 · $20
AstraZeneca UKLokelma$2,190
4 payments
  • Consulting · 2019-12-17 · $1,950
  • Meals for Farxiga · 2019-11-09 · $115
  • Meals for Lokelma · 2019-11-07 · $100
  • Meals for Lokelma · 2019-11-07 · $25
Vertex PharmaceuticalsNone$1,821
11 payments
  • Travel · 2019-07-02 · $658
  • Travel · 2019-07-02 · $72
  • Travel · 2019-07-02 · $18
  • Meals · 2019-07-02 · $5
  • Travel · 2019-06-24 · $665
  • Travel · 2019-06-24 · $84
  • Meals · 2019-06-24 · $39
  • Meals · 2019-06-24 · $26
  • Meals · 2019-06-24 · $58
  • Meals · 2019-06-24 · $26
  • Travel · 2019-06-23 · $171
Kyowa Hakko Kirin Co.None$1,101
2 payments
  • Consulting · 2019-11-25 · $1,000
  • Meals · 2019-11-25 · $101
AstraZeneca Pharmaceuticals LPNone$49
1 payment
  • Meals · 2019-02-06 · $49

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Amgen Inc. · Evolve · 2019Their institution$200,000
Bayer Healthcare Pharmaceuticals Inc. · Protocol Number 21177 (Study), Bay94-8862 Finerenone · 2025This clinician$38,950
Bayer Healthcare Pharmaceuticals Inc. · Bayer 19920-20186 Finerenone Study · 2025This clinician$27,000
Janssen Research & Development, LLC · Credence Study Investigating the Potential for Canagliflozin To Improve Renal Outcomes in Diabetes Patients · 2019Their institution$26,671
Amgen Inc. · Ph3 Kai 4169 Secondary Hpt 2 · 2019This clinician$12,699
Amgen Inc. · Etelcalcetide-Induced Changes in Serum Calcium and Bone Turnover Markers and the Severity of Second · 2020This clinician$6,193
Amgen Inc. · Parsabiv · 2019This clinician$5,022
Amgen Inc. · Fibroblast Growth Factor 23 As A Risk Factor for Cardiovascular Events and Mortality in Patients in · 2020This clinician$4,602
Bayer Healthcare Pharmaceuticals Inc. · Protocol Number 21177 Study Bay94-8862 · 2025This clinician$4,275
Amgen Inc. · Ph3 Kai 4169 Secondary Hpt Ole · 2019This clinician$3,072
Amgen Inc. · Ph3 Kai 4169 Secondary Hpt 1 · 2019This clinician$2,042
Gilead Sciences, Inc. · A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects With Moderate To Advanced Diabetic Kidney Disease · 2019This clinician$890
AKEBIA THERAPEUTICS INC · Akb-6548-Ci-0014 · 2019Their institution$420
Amgen Inc. · Evolve · 2019This clinician$33
Amgen Inc. · Ph3 Switch Study: Converting From Cinacalcet To Amg 416 · 2020This clinician$18

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1407823875
Licence
CA G84601California G84601: Current · expires 2028-05-31
Trained
Harvard Medical School, 1989
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CA 00G846010
Taxonomy
Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2006-03-03
NPI last updated
2024-04-18
NPI record certified
2024-04-18

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 774 11th Ave, San Francisco, CA, 94118